This HTML5 document contains 59 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q80607448
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en febreru de 2008 wetenschappelijk artikel artikull shkencor i botuar më 01 shkurt 2008 scientific article published on 01 February 2008 im Februar 2008 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 2008 наукова стаття, опублікована в лютому 2008
p:P577
wds:Q80607448-6E8E3BA1-964B-48C8-9B18-D9FC15493CEC
wdt:P577
2008-02-01T00:00:00Z
p:P407
wds:Q80607448-8FC4F328-F063-4962-BF4D-5AFD906A98B1
wdt:P407
wd:Q1860
p:P2093
wds:Q80607448-886E7ED0-B29D-4666-9C51-DC7544A80DFD wds:Q80607448-475E21D7-803A-4DCC-8FFC-C0F0EFE57343 wds:Q80607448-E9705638-C0F0-4AAA-976B-D5F611327564 wds:Q80607448-9F7DD84C-3ECD-47BD-AE98-89602118C78F wds:Q80607448-3005735A-1C01-445B-AA7A-11B3E16FA2A4 wds:Q80607448-2755083F-4F04-4A8E-9F45-1B96F991E2D6
wdt:P2093
Cecilie Kaufmann Knut Mikkelsen Marte Schrumpf Heiberg Erik Rødevand Petter Mowinckel Wenche Koldingsnes
rdfs:label
The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study
skos:prefLabel
The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study
schema:name
The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study
p:P50
wds:Q80607448-317A6679-5DBC-4FB6-A7F5-90A3E5F08F0B
wdt:P50
wd:Q65660760
p:P1476
wds:Q80607448-6CF9CB41-A070-4951-A9F4-9373F6D26FD2
wdt:P1476
The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study
p:P304
wds:Q80607448-4A659A8C-FF24-4909-882C-B4B701ED9589
wdt:P304
234-240
p:P31
wds:Q80607448-626A94B2-1982-4212-9837-ED26D31BF118
wdt:P31
wd:Q13442814
p:P921
wds:Q80607448-694EE6E3-0FB2-4A4C-A013-63FC47536021 wds:Q80607448-35A75B68-B05E-4791-93F0-007AD129272F wds:Q80607448-2E281F9E-BBE2-471E-BC27-2E89B3FC8D0F
wdt:P921
wd:Q187255 wd:Q52849 wd:Q511097
p:P698
wds:Q80607448-C7FD1F8D-1144-41F9-901E-85A9DC996365
wdtn:P698
n12:18240258
wdt:P698
18240258
p:P1433
wds:Q80607448-53BC7733-5F53-43C9-BC01-5CA0FDFF4CC5
wdt:P1433
wd:Q23929027
p:P433
wds:Q80607448-9A787794-34EA-48FD-8ED7-D4DD0C1E485C
p:P478
wds:Q80607448-F9F8FFF7-7D5E-491E-BCF6-5E18A4CF4F1D
wdt:P433
2
wdt:P478
59
p:P356
wds:Q80607448-3768E4FA-F60C-4C6E-8B5A-914E4737A8B7
wdtn:P356
n7:ART.23333
wdt:P356
10.1002/ART.23333